LH Stock May Gain From Select MAWD Pathology Asset Purchase Deal
Labcorp is set to acquire select assets of MAWD Pathology Group.
Be Patient, Earn Dividends From Labcorp, The Leading Patient Clinical Lab Brand
For my initial coverage of Labcorp, I'm calling it a hold, and an opportunity to earn a $0.72/share quarterly dividend on the leading clinical lab company in the US. The firm shows future growth in...
Outcomes4Me and Labcorp Study Reveals Digital Education Can Increase HER2-low Awareness for Metastatic Breast Cancer Patients
Research to be presented in a joint poster session with Labcorp at the 2024 San Antonio Breast Cancer Symposium BOSTON and BURLINGTON, N.C. , Nov. 26, 2024 /PRNewswire/ -- Outcomes4Me Inc., the dev...
Cinven secures Italian nod to sell minority stake in Synlab to Labcorp
Private equity firm Cinven secured a conditional approval from Italian authorities over its plan to sell a 15% stake in diagnostic service provider Synlab to laboratory operator Labcorp , a governm...
LH Beats on Q3 Earnings, Raises Revenue Guidance Midpoint, Stock Gains
Labcorp beats on earnings and revenues in the third quarter, entering the fourth half of 2024 with robust momentum.
Seeking Clues to Labcorp (LH) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Labcorp (LH), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the q...
Labcorp Declares Quarterly Dividend
BURLINGTON, N.C. , Oct. 10, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that its Board of Directors has declared a ...
Labcorp Stock Gains From Biopharma Business Amid FX Woe
LH is well-placed for long-term success in Cell & Gene Therapy, expanding into the consumer market and international growth through the specialty testing and biopharma business.
Labcorp to Announce Third Quarter Financial Results on October 24, 2024
BURLINGTON, N.C. , Sept. 24, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the third quarter o...
LH Stock Likely to Gain From the Molecular Bioanalytical Lab Expansion
Labcorp expands the molecular bioanalytical laboratory in Greenfield, IN.
Labcorp Stock Gains From Its Latest Acquisition of BioReference Health
LH completes the acquisition of BioReference Health, a wholly-owned subsidiary of OPKO Health. The acquisition includes BioReference Health's laboratory testing businesses.
Should You Hold Labcorp (LH) Stock in Your Portfolio Now?
Labcorp's (LH) slew of partnerships and acquisitions and robust efforts in high-growth areas bode well.
Labcorp (LH) Gains From New Collaborations Amid FX Issues
Labcorp's (LH) Biopharma Laboratory Services business is benefiting from collaborations with leading pharmaceutical and biotechnology companies.
Why Labcorp (LH) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Labcorp (LH) Tops Q1 Earnings Estimates, Raises 2024 EPS View
Labcorp (LH) sets a strong foundation for the year ahead with its impressive performance in the first quarter of 2024.
Related Companies